Racial disparities in utilization of specialist care and medications in inflammatory bowel disease

Geoffrey C. Nguyen, Thomas A. Laveist, Mary L. Harris, Ming Hsi Wang, Lisa W. Datta, Steven R. Brant

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objectives: Optimization of medical therapy and specialist care for inflammatory bowel disease (IBD) may reduce morbidity. We sought to characterize racial disparities in utilization of healthcare and medical therapy for IBD. Methods: We performed a cross-sectional study of black (n137) and white (n149) IBD patients recruited from an outpatient IBD clinic and through medical record review and telephone interview, compared utilization of IBD specialist services, emergency department (ED) services, and medications. We adjusted racial comparisons for demographic, socioeconomic, and clinical factors. Results: After adjustment for confounders, blacks were less likely than whites to be under the regular care (defined as at least annual visit) of a gastroenterologist (adjusted odds ratio (aOR) 0.43; 95% confidence interval (CI): 0.25-0.75) or IBD specialist (aOR 0.37; 95% CI: 0.22-0.61). Follow-up with a primary care provider was, however, similar between blacks and whites. Over the preceding 12 months, blacks were more likely than whites to have at least one visit to the ED (aOR 2.02; 95% CI: 1.22-3.35), but there was no difference in hospitalization. Among CD patients with prolonged steroid use, blacks were less likely than whites to have been on infliximab (aOR 0.41; 95% CI: 0.21-0.77), but there were no racial differences in the use of immunomodulators (aOR 0.87; 95% CI: 0.48-1.60). Conclusions: There are racial differences in utilization of IBD-related specialist services, ED visits, and infliximab that are independent of income and education. Modifiable barriers to health-care access may have a role in these disparities.

Original languageEnglish (US)
Pages (from-to)2202-2208
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume105
Issue number10
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Odds Ratio
Confidence Intervals
Hospital Emergency Service
Health Services Accessibility
Immunologic Factors
Medical Records
Primary Health Care
Hospitalization
Outpatients
Cross-Sectional Studies
Steroids
Demography
Interviews
Morbidity
Delivery of Health Care
Education
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Nguyen, G. C., Laveist, T. A., Harris, M. L., Wang, M. H., Datta, L. W., & Brant, S. R. (2010). Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. American Journal of Gastroenterology, 105(10), 2202-2208. https://doi.org/10.1038/ajg.2010.202

Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. / Nguyen, Geoffrey C.; Laveist, Thomas A.; Harris, Mary L.; Wang, Ming Hsi; Datta, Lisa W.; Brant, Steven R.

In: American Journal of Gastroenterology, Vol. 105, No. 10, 10.2010, p. 2202-2208.

Research output: Contribution to journalArticle

Nguyen, GC, Laveist, TA, Harris, ML, Wang, MH, Datta, LW & Brant, SR 2010, 'Racial disparities in utilization of specialist care and medications in inflammatory bowel disease', American Journal of Gastroenterology, vol. 105, no. 10, pp. 2202-2208. https://doi.org/10.1038/ajg.2010.202
Nguyen, Geoffrey C. ; Laveist, Thomas A. ; Harris, Mary L. ; Wang, Ming Hsi ; Datta, Lisa W. ; Brant, Steven R. / Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. In: American Journal of Gastroenterology. 2010 ; Vol. 105, No. 10. pp. 2202-2208.
@article{83e5caabbbe04e69b87f513d73480d98,
title = "Racial disparities in utilization of specialist care and medications in inflammatory bowel disease",
abstract = "Objectives: Optimization of medical therapy and specialist care for inflammatory bowel disease (IBD) may reduce morbidity. We sought to characterize racial disparities in utilization of healthcare and medical therapy for IBD. Methods: We performed a cross-sectional study of black (n137) and white (n149) IBD patients recruited from an outpatient IBD clinic and through medical record review and telephone interview, compared utilization of IBD specialist services, emergency department (ED) services, and medications. We adjusted racial comparisons for demographic, socioeconomic, and clinical factors. Results: After adjustment for confounders, blacks were less likely than whites to be under the regular care (defined as at least annual visit) of a gastroenterologist (adjusted odds ratio (aOR) 0.43; 95{\%} confidence interval (CI): 0.25-0.75) or IBD specialist (aOR 0.37; 95{\%} CI: 0.22-0.61). Follow-up with a primary care provider was, however, similar between blacks and whites. Over the preceding 12 months, blacks were more likely than whites to have at least one visit to the ED (aOR 2.02; 95{\%} CI: 1.22-3.35), but there was no difference in hospitalization. Among CD patients with prolonged steroid use, blacks were less likely than whites to have been on infliximab (aOR 0.41; 95{\%} CI: 0.21-0.77), but there were no racial differences in the use of immunomodulators (aOR 0.87; 95{\%} CI: 0.48-1.60). Conclusions: There are racial differences in utilization of IBD-related specialist services, ED visits, and infliximab that are independent of income and education. Modifiable barriers to health-care access may have a role in these disparities.",
author = "Nguyen, {Geoffrey C.} and Laveist, {Thomas A.} and Harris, {Mary L.} and Wang, {Ming Hsi} and Datta, {Lisa W.} and Brant, {Steven R.}",
year = "2010",
month = "10",
doi = "10.1038/ajg.2010.202",
language = "English (US)",
volume = "105",
pages = "2202--2208",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Racial disparities in utilization of specialist care and medications in inflammatory bowel disease

AU - Nguyen, Geoffrey C.

AU - Laveist, Thomas A.

AU - Harris, Mary L.

AU - Wang, Ming Hsi

AU - Datta, Lisa W.

AU - Brant, Steven R.

PY - 2010/10

Y1 - 2010/10

N2 - Objectives: Optimization of medical therapy and specialist care for inflammatory bowel disease (IBD) may reduce morbidity. We sought to characterize racial disparities in utilization of healthcare and medical therapy for IBD. Methods: We performed a cross-sectional study of black (n137) and white (n149) IBD patients recruited from an outpatient IBD clinic and through medical record review and telephone interview, compared utilization of IBD specialist services, emergency department (ED) services, and medications. We adjusted racial comparisons for demographic, socioeconomic, and clinical factors. Results: After adjustment for confounders, blacks were less likely than whites to be under the regular care (defined as at least annual visit) of a gastroenterologist (adjusted odds ratio (aOR) 0.43; 95% confidence interval (CI): 0.25-0.75) or IBD specialist (aOR 0.37; 95% CI: 0.22-0.61). Follow-up with a primary care provider was, however, similar between blacks and whites. Over the preceding 12 months, blacks were more likely than whites to have at least one visit to the ED (aOR 2.02; 95% CI: 1.22-3.35), but there was no difference in hospitalization. Among CD patients with prolonged steroid use, blacks were less likely than whites to have been on infliximab (aOR 0.41; 95% CI: 0.21-0.77), but there were no racial differences in the use of immunomodulators (aOR 0.87; 95% CI: 0.48-1.60). Conclusions: There are racial differences in utilization of IBD-related specialist services, ED visits, and infliximab that are independent of income and education. Modifiable barriers to health-care access may have a role in these disparities.

AB - Objectives: Optimization of medical therapy and specialist care for inflammatory bowel disease (IBD) may reduce morbidity. We sought to characterize racial disparities in utilization of healthcare and medical therapy for IBD. Methods: We performed a cross-sectional study of black (n137) and white (n149) IBD patients recruited from an outpatient IBD clinic and through medical record review and telephone interview, compared utilization of IBD specialist services, emergency department (ED) services, and medications. We adjusted racial comparisons for demographic, socioeconomic, and clinical factors. Results: After adjustment for confounders, blacks were less likely than whites to be under the regular care (defined as at least annual visit) of a gastroenterologist (adjusted odds ratio (aOR) 0.43; 95% confidence interval (CI): 0.25-0.75) or IBD specialist (aOR 0.37; 95% CI: 0.22-0.61). Follow-up with a primary care provider was, however, similar between blacks and whites. Over the preceding 12 months, blacks were more likely than whites to have at least one visit to the ED (aOR 2.02; 95% CI: 1.22-3.35), but there was no difference in hospitalization. Among CD patients with prolonged steroid use, blacks were less likely than whites to have been on infliximab (aOR 0.41; 95% CI: 0.21-0.77), but there were no racial differences in the use of immunomodulators (aOR 0.87; 95% CI: 0.48-1.60). Conclusions: There are racial differences in utilization of IBD-related specialist services, ED visits, and infliximab that are independent of income and education. Modifiable barriers to health-care access may have a role in these disparities.

UR - http://www.scopus.com/inward/record.url?scp=77957841554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957841554&partnerID=8YFLogxK

U2 - 10.1038/ajg.2010.202

DO - 10.1038/ajg.2010.202

M3 - Article

C2 - 20485281

AN - SCOPUS:77957841554

VL - 105

SP - 2202

EP - 2208

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -